Forkhead transcription factors in chronic inflammation

International Journal of Biochemistry and Cell Biology

Volumn 42, Issue 4, 2010, Pages 482-485

  Peng, Stanford L ^a  

^a BENAROYA RESEARCH INSTITUTE   (United States)

Author keywords

Autoimmunity; Forkhead; Lymphocytes; Neutrophils; Transcription factors

Indexed keywords

FORKHEAD TRANSCRIPTION FACTOR; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TRANSCRIPTION FACTOR FOXJ1; TRANSCRIPTION FACTOR FOXP3; UNCLASSIFIED DRUG;

ALLERGIC DISEASE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ T LYMPHOCYTE; CHRONIC INFLAMMATION; EFFECTOR CELL; GENE EXPRESSION; HUMAN; INFLAMMATORY DISEASE; LYMPHOCYTE FUNCTION; NEUTROPHIL; NONHUMAN; PROTEIN FAMILY; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; REVIEW; RHEUMATOID ARTHRITIS;

ANIMALS; AUTOIMMUNITY; CHRONIC DISEASE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INFLAMMATION; LYMPHOCYTES; NEUTROPHILS;

EID: 77649237488     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2009.10.013     Document Type: Review

References (67)

1. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 19 (2007) 345-354
2. Amin R.H., and Schlissel M.S. Foxo1 directly regulates the transcription of recombination-activating genes during B cell development. Nat Immunol 9 (2008) 613-622
3. Bacchetta R., Gambineri E., and Roncarolo M.G. Role of regulatory T cells and FOXP3 in human diseases. J Allergy Clin Immunol 120 (2007) 227-235
4. + regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 177 (2006) 8338-8347
5. + T cells derived from the majority of atopic donors are able to suppress TH1 and TH2 cytokine production. J Allergy Clin Immunol 111 (2003) 862-868
6. Bennett C.L., Christie J., Ramsdell F., Brunkow M.E., Ferguson P.J., Whitesell L., et al. The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 27 (2001) 20-21
7. Bettelli E., Oukka M., and Kuchroo V.K. T(H)-17 cells in the circle of immunity and autoimmunity. Nat Immunol 8 (2007) 345-350
8. Brunkow M.E., Jeffery E.W., Hjerrild K.A., Paeper B., Clark L.B., Yasayko S.A., et al. Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27 (2001) 68-73
9. + T-cells in type 1 diabetes. Diabetes 54 (2005) 1407-1414
10. Campbell D.J., and Ziegler S.F. FOXP3 modifies the phenotypic and functional properties of regulatory T cells. Nat Rev Immunol 7 (2007) 305-310
11. Carlsson P., and Mahlapuu M. Forkhead transcription factors: key players in development and metabolism. Dev Biol 250 (2002) 1-23
12. + regulatory T cells by TGF-beta induction of transcription factor Foxp3. J Exp Med 198 (2003) 1875-1886
13. Cui M., Huang Y., Zhao Y., and Zheng J. Transcription factor FOXO3a mediates apoptosis in HIV-1-infected macrophages. J Immunol 180 (2008) 898-906
14. + T lymphocytes. J Immunol 181 (2008) 8460-8477
15. + T regulatory cells. J Immunol 178 (2007) 4022-4026
16. Dengler H.S., Baracho G.V., Omori S.A., Bruckner S., Arden K.C., Castrillon D.H., et al. Distinct functions for the transcription factor Foxo1 at various stages of B cell differentiation. Nat Immunol 9 (2008) 1388-1398
17. Fabre S., Carrette F., Chen J., Lang V., Semichon M., Denoyelle C., et al. FOXO1 regulates L-selectin and a network of human T cell homing molecules downstream of phosphatidylinositol 3-kinase. J Immunol 181 (2008) 2980-2989
18. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 445 (2007) 771-775
19. Geborek P., Bladstrom A., Turesson C., Gulfe A., Petersson I.F., Saxne T., et al. Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas. Ann Rheum Dis 64 (2005) 699-703
20. Hur E.M., Youssef S., Haws M.E., Zhang S.Y., Sobel R.A., and Steinman L. Osteopontin-induced relapse and progression of autoimmune brain disease through enhanced survival of activated T cells. Nat Immunol 8 (2007) 74-83
21. Jonsson H., Allen P., and Peng S.L. Inflammatory arthritis requires Foxo3a to prevent Fas ligand-induced neutrophil apoptosis. Nat Med 11 (2005) 666-671
22. Jonsson H., and Peng S.L. Forkhead transcription factors in immunology. Cell Mol Life Sci 62 (2005) 397-409
23. + regulatory T cells in children who have outgrown cow's milk allergy. J Exp Med 199 (2004) 1679-1688
24. Kerdiles Y.M., Beisner D.R., Tinoco R., Dejean A.S., Castrillon D.H., DePinho R.A., et al. Foxo1 links homing and survival of naive T cells by regulating L-selectin, CCR7 and interleukin 7 receptor. Nat Immunol 10 (2009) 176-184
25. + regulatory T cells in autoimmune polyglandular syndrome type II. J Exp Med 199 (2004) 1285-1291
26. Kuo C.C., and Lin S.C. Altered FOXO1 transcript levels in peripheral blood mononuclear cells of systemic lupus erythematosus and rheumatoid arthritis patients. Mol Med 13 (2007) 561-566
27. Laurence A., Tato C.M., Davidson T.S., Kanno Y., Chen Z., Yao Z., et al. Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26 (2007) 371-381
28. + regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma. Clin Exp Immunol 148 (2007) 53-63
29. Li C.S., Zhang Q., Lim M.K., Sheen D.H., Shim S.C., Kim J.Y., et al. Association of FOXJ1 polymorphisms with systemic lupus erythematosus and rheumatoid arthritis in Korean population. Exp Mol Med 39 (2007) 805-811
30. Lin L., Brody S.L., and Peng S.L. Restraint of B cell activation by Foxj1-mediated antagonism of NF-kappa B and IL-6. J Immunol 175 (2005) 951-958
31. Lin L., Hron J.D., and Peng S.L. Regulation of NF-kappaB, Th activation, and autoinflammation by the forkhead transcription factor Foxo3a. Immunity 21 (2004) 203-213
32. Lin L., and Peng S.L. Coordination of NF-kappaB and NFAT antagonism by the forkhead transcription factor Foxd1. J Immunol 176 (2006) 4793-4803
33. Lin L., Spoor M.S., Gerth A.J., Brody S.L., and Peng S.L. Modulation of Th1 activation and inflammation by the NF-kappaB repressor Foxj1. Science 303 (2004) 1017-1020
34. Lindley S., Dayan C.M., Bishop A., Roep B.O., Peakman M., and Tree T.I. Defective suppressor function in CD4(+)CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54 (2005) 92-99
35. Ludikhuize J., de Launay D., Groot D., Smeets T.J., Vinkenoog M., Sanders M.E., et al. Inhibition of forkhead box class O family member transcription factors in rheumatoid synovial tissue. Arthritis Rheum 56 (2007) 2180-2191
36. Marazuela M., Garcia-Lopez M.A., Figueroa-Vega N., de la Fuente H., Varado-Sanchez B., Monsivais-Urenda A., et al. Regulatory T cells in human autoimmune thyroid disease. J Clin Endocrinol Metab 91 (2006) 3639-3646
37. Miyara M., Amoura Z., Parizot C., Badoual C., Dorgham K., Trad S., et al. The immune paradox of sarcoidosis and regulatory T cells. J Exp Med 203 (2006) 359-370
38. + T cells with the phenotypic and functional characteristics of regulatory T cells are enriched in the synovial fluid of patients with rheumatoid arthritis. Clin Exp Immunol 140 (2005) 360-367
39. Nomura T., and Sakaguchi S. Foxp3 and Aire in thymus-generated Treg cells: a link in self-tolerance. Nat Immunol 8 (2007) 333-334
40. Ouyang W., Beckett O., Flavell R.A., and Li M.O. An essential role of the Forkhead-box transcription factor Foxo1 in control of T cell homeostasis and tolerance. Immunity 30 (2009) 358-371
41. + T lymphocytes. J Immunol 178 (2007) 732-739
42. Peng S.L. Foxo in the immune system. Oncogene 27 (2008) 2337-2344
43. Peng S.L. Transcription factors in autoimmune diseases. Front Biosci 13 (2008) 4218-4240
44. + T regulatory cells are not altered in multiple sclerosis and unaffected by disease-modulating drugs. J Clin Immunol 24 (2004) 155-161
45. high regulatory T cells in human autoimmune diabetes. J Autoimmun 24 (2005) 55-62
46. Roncarolo M.G., Gregori S., Battaglia M., Bacchetta R., Fleischhauer K., and Levings M.K. Interleukin-10-secreting type 1 regulatory T cells in rodents and humans. Immunol Rev 212 (2006) 28-50
47. Sakaguchi S., Yamaguchi T., Nomura T., Ono M., and Regulatory. T cells and immune tolerance. Cell 133 (2008) 775-787
48. Sela U., Dayan M., Hershkoviz R., Cahalon L., Lider O., and Mozes E. The negative regulators Foxj1 and Foxo3a are up-regulated by a peptide that inhibits systemic lupus erythematosus-associated T cell responses. Eur J Immunol 36 (2006) 2971-2980
49. + T lymphocytes in peripheral blood from patients with atopic asthma. Clin Immunol 113 (2004) 172-178
50. Srivatsan S., and Peng S.L. Cutting edge: Foxj1 protects against autoimmunity and inhibits thymocyte egress. J Immunol 175 (2005) 7805-7809
51. Stockinger B. Good for goose, but not for gander: IL-2 interferes with Th17 differentiation. Immunity 26 (2007) 278-279
52. Stockinger B., and Veldhoen M. Differentiation and function of Th17 T cells. Curr Opin Immunol 19 (2007) 281-286
53. + regulatory T cell: a jack of all trades, master of regulation. Nat Immunol 9 (2008) 239-244
54. Tran H, Brunet A, Griffith EC, Greenberg ME. The many forks in FOXO's road. Sci STKE 2003;2003:RE5.
55. Turrel-Davin F., Tournadre A., Pachot A., Arnaud B., Cazalis M.A., Mougin B., et al. FoxO3a involved in neutrophil and T cell survival is overexpressed in rheumatoid blood and synovial tissue. Ann Rheum Dis (2009) 10.1136/ard.2009.109991
56. van Amelsfort J.M., Jacobs K.M., Bijlsma J.W., Lafeber F.P., and Taams L.S. CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 50 (2004) 2775-2785
57. + regulatory T cell-mediated suppression in rheumatoid arthritis. Arthritis Rheum 56 (2007) 732-742
58. van Dongen G.A., Visser G.W., and Vrouenraets M.B. Photosensitizer-antibody conjugates for detection and therapy of cancer. Adv Drug Deliv Rev 56 (2004) 31-52
59. van Grevenynghe J., Halwani R., Chomont N., Ancuta P., Peretz Y., Tanel A., et al. Lymph node architecture collapse and consequent modulation of FOXO3a pathway on memory T- and B-cells during HIV infection. Semin Immunol 20 (2008) 196-203
60. van Grevenynghe J., Procopio F.A., He Z., Chomont N., Riou C., Zhang Y., et al. Transcription factor FOXO3a controls the persistence of memory CD4(+) T cells during HIV infection. Nat Med 14 (2008) 266-274
61. + regulatory T cells in patients with multiple sclerosis. J Exp Med 199 (2004) 971-979
62. +. Proc Natl Acad Sci USA 102 (2005) 4103-4108
63. + T cells. Eur J Immunol 37 (2007) 129-138
64. Weiner H.L. Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 182 (2001) 207-214
65. Wildin R.S., Ramsdell F., Peake J., Faravelli F., Casanova J.L., Buist N., et al. X-linked neonatal diabetes mellitus, enteropathy and endocrinopathy syndrome is the human equivalent of mouse scurfy. Nat Genet 27 (2001) 18-20
66. + regulatory T cells in ulcerative colitis. Inflamm Bowel Dis 13 (2007) 191-199
67. + regulatory T cells through a STAT-dependent mechanism and induces the expansion of these cells in vivo. Blood 108 (2006) 1571-1579